| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 124 |
| 1 | METHOTREXATE SODIUM | 104 |
| 2 | METHOTREXATE | 82 |
| 3 | CETUXIMAB | 77 |
| 4 | PREDNISONE | 74 |
| 5 | OMEPRAZOLE MAGNESIUM | 59 |
| 6 | OMEPRAZOLE | 52 |
| 7 | CYTARABINE | 51 |
| 8 | CISPLATIN | 46 |
| 9 | DEXAMETHASONE | 44 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 170 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 129 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 94 |
| 3 | Platinum-based Drug [EPC] | 89 |
| 4 | Proton Pump Inhibitor [EPC] | 89 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 80 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 69 |
| 7 | Benzodiazepine [EPC] | 61 |
| 8 | Alkylating Drug [EPC] | 58 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 50 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 5 | 0.0034 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 80 | 0.0017 |
| 3 | Actinomycin [EPC] | 3 | 0.0014 |
| 4 | Provitamin D2 Compound [EPC] | 33 | 0.0011 |
| 5 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 6 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 7 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 8 | Interleukin-17A Antagonist [EPC] | 27 | 0.0007 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |